HomeCompanies › CRVO

CervoMed

Most recent annual filing: 2026-03-15

Catalyst timeline

4 trackedQuarter catalyst calendar →
  1. Neflamapimod FTD readoutmid-2026Neflamapimod FTD readout, mid-2026, notable
  2. Neflamapimod DLB Ph3 start2H 2026Neflamapimod DLB Ph3 start, 2H 2026, material
  3. Neflamapimod RESTORE topline2H 2026Neflamapimod RESTORE topline, 2H 2026, material
  4. Cash runway guidance update3Q 2027Cash runway guidance update, 3Q 2027, routine

Bar width shows how precise the guidance is — a pin is a stated date, a wide band a six-month window. Deeper blue means more of the thesis rides on the event; it is not a view on the stock.

Pipeline (4 active programs)

Discontinued (1)

Biotech Distilled coverage (13)

Articles open on Substack. Some deep dives are subscriber-only.